Year: 2018
Type: article
Abstract: Governments should use patents to shape the deployment of CRISPR–Cas9 as they have done for past technologies, argues Shobita Parthasarathy. Governments should use patents to shape the deployment of CRISPR–Cas9 as they have done for past technologies, argues Shobita Parthasarathy.
Source: Nature
Author: Shobita Parthasarathy
Institution: University of Michigan
Language: English
Subfield: Management of Technology and Innovation
Domain: Social Sciences
Open Access status: hybrid
Estimated APC paid: $12,690
OpenAlex ID: W2896408231
